AnaptysBio, Inc.
ANAB
$43.22
-$0.54-1.23%
NASDAQ
| 09/30/2025 | 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | |
|---|---|---|---|---|---|
| Total Cash And Short-Term Investments | 248.96M | 265.71M | 339.94M | 385.37M | 430.12M |
| Total Receivables | 75.69M | 21.42M | 17.88M | 40.77M | 12.20M |
| Inventory | -- | -- | -- | -- | -- |
| Prepaid Expenses | 6.01M | 4.78M | 5.29M | 5.74M | 6.37M |
| Finance Division Loans and Leases Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Current Assets | -- | -- | -- | -- | -- |
| Other Current Assets | -- | -- | -- | -- | -- |
| Total Current Assets | 330.65M | 291.91M | 363.11M | 431.88M | 448.68M |
|
|
|||||
| Total Current Assets | 330.65M | 291.91M | 363.11M | 431.88M | 448.68M |
| Net Property, Plant & Equipment | 14.49M | 15.09M | 15.66M | 16.23M | 16.57M |
| Long-term Investments | -- | -- | -- | -- | -- |
| Goodwill | -- | -- | -- | -- | -- |
| Total Other Intangibles | -- | -- | -- | -- | -- |
| Finance Div Loans & Leases LT | -- | -- | -- | -- | -- |
| Total Finance Div Other LT Assets | -- | -- | -- | -- | -- |
| Total Other Assets | 256.00K | 256.00K | 256.00K | 256.00K | 256.00K |
| Total Assets | 353.10M | 335.25M | 422.05M | 483.83M | 493.42M |
|
|
|||||
| Total Accounts Payable | 2.89M | 3.33M | 6.12M | 4.00M | 3.59M |
| Total Accrued Expenses | 32.62M | 29.72M | 31.45M | 39.50M | 37.95M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Current Portion of Long-Term Debt/Capital Leases | -- | -- | -- | -- | -- |
| Finance Division Debt Current | 2.04M | 2.00M | 1.96M | 1.93M | 1.89M |
| Total Finance Division Other Current Liabilities | 554.00K | 480.00K | 4.50M | -- | 456.00K |
| Total Other Current Liabilities | 554.00K | 480.00K | 4.50M | -- | 456.00K |
| Total Current Liabilities | 38.10M | 35.53M | 44.04M | 45.43M | 43.88M |
|
|
|||||
| Total Current Liabilities | 38.10M | 35.53M | 44.04M | 45.43M | 43.88M |
| Long-Term Debt | 331.84M | 331.36M | 330.38M | 353.43M | 350.56M |
| Short-term Debt | -- | -- | -- | -- | -- |
| Capital Leases | 12.57M | 13.10M | 13.61M | 14.11M | 14.61M |
| Finance Division Debt Non Current | -- | -- | -- | -- | -- |
| Total Finance Division Other Non Current Liabilities | -- | -- | -- | -- | -- |
| Total Other Liabilities | -- | -- | -- | -- | -- |
| Total Liabilities | 382.51M | 379.98M | 388.03M | 412.97M | 409.05M |
|
|
|||||
| Common Stock & APIC | 792.71M | 792.56M | 832.52M | 829.89M | 821.15M |
| Retained Earnings | -822.17M | -837.29M | -798.66M | -759.33M | -737.54M |
| Treasury Stock & Other | 47.00K | -6.00K | 161.00K | 305.00K | 759.00K |
| Total Common Equity | -29.42M | -44.73M | 34.02M | 70.87M | 84.37M |
|
|
|||||
| Preferred Stock Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Non Redeemable | -- | -- | -- | -- | -- |
| Preferred Stock Convertible | -- | -- | -- | -- | -- |
| Preferred Stock, Others | -- | -- | -- | -- | -- |
| Total Preferred Equity | -- | -- | -- | -- | -- |
|
|
|||||
| Total Common Equity | -29.42M | -44.73M | 34.02M | 70.87M | 84.37M |
| Total Preferred Equity | -- | -- | -- | -- | -- |
| Total Minority Interest | -- | -- | -- | -- | -- |
| Total Equity | -29.42M | -44.73M | 34.02M | 70.87M | 84.37M |
|
|
|||||